Leaflet P.P.D I.C 65-10 UT 10 UT / 0.1ml solution for injection


Indicated for: diagnosis of tuberculosis infection

Route of administration: injectable

Substance: antigens for IDR (tuberculin) (allergenic extract)

ATC: V04CF01 (Various | Other diagnostic agents | Tuberculosis diagnostics)

Precautions:
Anaphylaxis
Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Antigens for IDR (intradermal reaction), known as tuberculin, are used for diagnosing infection with Mycobacterium tuberculosis, the bacterium that causes tuberculosis. The tuberculin skin test, also known as the Mantoux test, is a standardized method for detecting an immune reaction to tuberculin, indicating possible exposure to the tuberculosis bacillus.

The test involves intradermal injection of a small amount of tuberculin into the forearm. After 48-72 hours, the injection site is examined to determine the presence and size of an induration (swelling). The test result is interpreted based on the size of the induration and the patient's risk factors.

Adverse reactions are rare but may include redness, itching, or irritation at the injection site. In very rare cases, severe allergic reactions may occur.

Antigens for IDR are an important tool in tuberculosis control, helping to identify infected individuals and prevent the spread of the disease.

General data about P.P.D I.C 65-10 UT 10 UT / 0.1ml

  • Substance: antigens for IDR (tuberculin)
  • Date of last drug list: 01-07-2013
  • Commercial code: W13838001
  • Concentration: 10 UT / 0.1ml
  • Pharmaceutical form: solution for injection
  • Quantity: 50
  • Product type: generic
  • Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.

Concentrations available for antigens for IDR (tuberculin)

  • 10 UT/0.1ml
  • 2 UT/0.1ml